CHIT1 and frontotemporal dementia: Although in a preliminary phase, CHIT1 and YKL-40 appear to be raised in symptomatic genetic FTD compared to asymptomatic mutation carriers and controls, suggesting that neuroinflammatory cell activities manifested over the symptomatic disease phase [118].